Literature DB >> 17699192

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Kyongtae T Bae1, Fang Zhu, Arlene B Chapman, Vicente E Torres, Jared J Grantham, Lisa M Guay-Woodford, Deborah A Baumgarten, Bernard F King, Louis H Wetzel, Philip J Kenney, Marijn E Brummer, William M Bennett, Saulo Klahr, Catherine M Meyers, Xiaoling Zhang, Paul A Thompson, J Philip Miller.   

Abstract

The objective of this study was to investigate the prevalence of hepatic cysts by age and gender in patients with early autosomal-dominant polycystic kidney disease (ADPKD) and to determine whether hepatic cyst volume is related to renal and renal cyst volumes by using magnetic resonance imaging (MRI). A total of 230 patients with ADPKD (94 men and 136 women) who were aged 15 to 46 yr and had relatively preserved renal function were studied. MRI images of the kidney and liver were obtained to measure renal, renal cyst, and hepatic cyst volumes. These volume measurements and hepatic cyst prevalence were compared in all patients and in subgroups on the basis of gender and age (15 to 24, 25 to 34, and 35 to 46 yr). The overall prevalence of hepatic cysts was 83%; the prevalence was 58, 85, and 94% in the sequential age groups and 85% in women and 79% in men. The prevalence was related directly to renal volume (chi2 = 4.30, P = 0.04) and to renal cyst volume (chi2 = 5.59, P = 0.02). The total hepatic cyst volume was significantly greater in women than in men (a logarithmic transformation mean of 5.27 versus 1.94 ml; P = 0.003). The average hepatic cyst volume was 0.25, 5.75, and 22.78 ml in sequential age groups. Hepatic cysts are evident in 94% of patients who are older than 35 yr and in 55% of individuals who are younger than 25 yr. Hepatic cysts are more prevalent and larger in total cyst volume in women than in men. Hepatic cyst prevalence and aggregate total hepatic cyst volume increased with age.

Entities:  

Mesh:

Year:  2005        PMID: 17699192     DOI: 10.2215/CJN.00080605

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  121 in total

Review 1.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

2.  A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection.

Authors:  Taro Akihisa; Ayami Ino; Hiroto Egawa; Yoshihito Kotera; Shunichi Ariizumi; Akiko Oomori; Shingo Yamashita; Yusuke Yamamoto; Ken Tsuchiya; Masakazu Yamamoto; Kosaku Nitta; Toshio Mochizuki
Journal:  CEN Case Rep       Date:  2018-06-28

Review 3.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

Review 4.  Liver and kidney disease in ciliopathies.

Authors:  Meral Gunay-Aygun
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-11-15       Impact factor: 3.908

5.  The relationship between liver cyst volume and QOL in Japanese ADPKD patients.

Authors:  Satoru Muto; Masahiko Ando; Saori Nishio; Kazushige Hanaoka; Yoshifumi Ubara; Ichiei Narita; Kouichi Kamura; Toshio Mochizuki; Ken Tsuchiya; Kazuhiko Tsuruya; Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2019-12-26       Impact factor: 2.801

6.  Volume regression of native polycystic kidneys after renal transplantation.

Authors:  Yeonsoon Jung; María V Irazabal; Fouad T Chebib; Peter C Harris; Patrick G Dean; Mikel Prieto; Fernando G Cosio; Ziad M El-Zoghby; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2015-06-04       Impact factor: 5.992

Review 7.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

8.  PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.

Authors:  Ronak Lakhia; Matanel Yheskel; Andrea Flaten; Ezekiel B Quittner-Strom; William L Holland; Vishal Patel
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-13

9.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

10.  Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.

Authors:  Kyungsoo Bae; Bumwoo Park; Hongliang Sun; Jinhong Wang; Cheng Tao; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Michal Mrug; William M Bennett; Michael F Flessner; Doug P Landsittel; Kyongtae T Bae
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.